A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
Clinical trial NCT04303195 · COMPLETED
Trial details
- NCT number
- NCT04303195
- Sponsor
- Neurogastrx, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2023-02-25
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.